Global Adoptive Cellular ImmunOthersapy Market Research Report 2025(Status and Outlook)
Report Overview
Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.
This report provides a deep insight into the global Adoptive Cellular ImmunOthersapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Adoptive Cellular ImmunOthersapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Adoptive Cellular ImmunOthersapy market in any manner.
Global Adoptive Cellular ImmunOthersapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
Market Segmentation (by Type)
TIL
LAK
CAR-T
TCR-T
CIK
NK
DC
Others
Market Segmentation (by Application)
Hospital
Cancer Hospital
Centers for Disease Control and Prevention
Rehabilitation Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Adoptive Cellular ImmunOthersapy Market
Overview of the regional outlook of the Adoptive Cellular ImmunOthersapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Adoptive Cellular ImmunOthersapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Adoptive Cellular ImmunOthersapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Adoptive cellular immunity is the transfer of lymphocytes from the donor to the recipient to enhance its cellular immunity.
This report provides a deep insight into the global Adoptive Cellular ImmunOthersapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Adoptive Cellular ImmunOthersapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Adoptive Cellular ImmunOthersapy market in any manner.
Global Adoptive Cellular ImmunOthersapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen Inc
Autolus Therapeutics Plc
Beijing Immunochina Medical Science & Technology Co Ltd
Bellicum Pharmaceuticals Inc
Bristol-Myers Squibb Co
bluebird bio Inc
CARsgen Therapeutics Ltd
Celgene Corp
Cell Medica Ltd
Cellular Biomedicine Group Inc
Celularity Inc
Celyad SA
Daiichi Sankyo Co Ltd
Fosun Pharmaceutical AG
Gilead Sciences Inc
Guangzhou Anjie Biomedical Technology Co Ltd
Hangzhou Converd Co Ltd
Hebei Senlang Biotechnology Inc Ltd
HRAIN Biotechnology Co Ltd
Juno Therapeutics Inc
Kite Pharma Inc
Nanjing Legend Biotech Co Ltd
NantKwest Inc
Nkarta Inc
Novartis AG
Ono Pharmaceutical Co Ltd
Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
Sorrento Therapeutics Inc
Takara Bio Inc
Market Segmentation (by Type)
TIL
LAK
CAR-T
TCR-T
CIK
NK
DC
Others
Market Segmentation (by Application)
Hospital
Cancer Hospital
Centers for Disease Control and Prevention
Rehabilitation Center
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Adoptive Cellular ImmunOthersapy Market
Overview of the regional outlook of the Adoptive Cellular ImmunOthersapy Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Adoptive Cellular ImmunOthersapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Adoptive Cellular ImmunOthersapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Adoptive Cellular ImmunOthersapy
1.2 Key Market Segments
1.2.1 Adoptive Cellular ImmunOthersapy Segment by Type
1.2.2 Adoptive Cellular ImmunOthersapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Adoptive Cellular ImmunOthersapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Adoptive Cellular ImmunOthersapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Adoptive Cellular ImmunOthersapy Product Life Cycle
3.3 Global Adoptive Cellular ImmunOthersapy Sales by Manufacturers (2020-2025)
3.4 Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Adoptive Cellular ImmunOthersapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Adoptive Cellular ImmunOthersapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Adoptive Cellular ImmunOthersapy Market Competitive Situation and Trends
3.8.1 Adoptive Cellular ImmunOthersapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Adoptive Cellular ImmunOthersapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ADOPTIVE CELLULAR IMMUNOTHERSAPY INDUSTRY CHAIN ANALYSIS
4.1 Adoptive Cellular ImmunOthersapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Adoptive Cellular ImmunOthersapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Adoptive Cellular ImmunOthersapy Market
5.7 ESG Ratings of Leading Companies
6 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adoptive Cellular ImmunOthersapy Sales Market Share by Type (2020-2025)
6.3 Global Adoptive Cellular ImmunOthersapy Market Size Market Share by Type (2020-2025)
6.4 Global Adoptive Cellular ImmunOthersapy Price by Type (2020-2025)
7 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adoptive Cellular ImmunOthersapy Market Sales by Application (2020-2025)
7.3 Global Adoptive Cellular ImmunOthersapy Market Size (M USD) by Application (2020-2025)
7.4 Global Adoptive Cellular ImmunOthersapy Sales Growth Rate by Application (2020-2025)
8 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET SALES BY REGION
8.1 Global Adoptive Cellular ImmunOthersapy Sales by Region
8.1.1 Global Adoptive Cellular ImmunOthersapy Sales by Region
8.1.2 Global Adoptive Cellular ImmunOthersapy Sales Market Share by Region
8.2 Global Adoptive Cellular ImmunOthersapy Market Size by Region
8.2.1 Global Adoptive Cellular ImmunOthersapy Market Size by Region
8.2.2 Global Adoptive Cellular ImmunOthersapy Market Size Market Share by Region
8.3 North America
8.3.1 North America Adoptive Cellular ImmunOthersapy Sales by Country
8.3.2 North America Adoptive Cellular ImmunOthersapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Adoptive Cellular ImmunOthersapy Sales by Country
8.4.2 Europe Adoptive Cellular ImmunOthersapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Adoptive Cellular ImmunOthersapy Sales by Region
8.5.2 Asia Pacific Adoptive Cellular ImmunOthersapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Adoptive Cellular ImmunOthersapy Sales by Country
8.6.2 South America Adoptive Cellular ImmunOthersapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Adoptive Cellular ImmunOthersapy Sales by Region
8.7.2 Middle East and Africa Adoptive Cellular ImmunOthersapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Adoptive Cellular ImmunOthersapy by Region(2020-2025)
9.2 Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Region (2020-2025)
9.3 Global Adoptive Cellular ImmunOthersapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Adoptive Cellular ImmunOthersapy Production
9.4.1 North America Adoptive Cellular ImmunOthersapy Production Growth Rate (2020-2025)
9.4.2 North America Adoptive Cellular ImmunOthersapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Adoptive Cellular ImmunOthersapy Production
9.5.1 Europe Adoptive Cellular ImmunOthersapy Production Growth Rate (2020-2025)
9.5.2 Europe Adoptive Cellular ImmunOthersapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Adoptive Cellular ImmunOthersapy Production (2020-2025)
9.6.1 Japan Adoptive Cellular ImmunOthersapy Production Growth Rate (2020-2025)
9.6.2 Japan Adoptive Cellular ImmunOthersapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Adoptive Cellular ImmunOthersapy Production (2020-2025)
9.7.1 China Adoptive Cellular ImmunOthersapy Production Growth Rate (2020-2025)
9.7.2 China Adoptive Cellular ImmunOthersapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Amgen Inc
10.1.1 Amgen Inc Basic Information
10.1.2 Amgen Inc Adoptive Cellular ImmunOthersapy Product Overview
10.1.3 Amgen Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.1.4 Amgen Inc Business Overview
10.1.5 Amgen Inc SWOT Analysis
10.1.6 Amgen Inc Recent Developments
10.2 Autolus Therapeutics Plc
10.2.1 Autolus Therapeutics Plc Basic Information
10.2.2 Autolus Therapeutics Plc Adoptive Cellular ImmunOthersapy Product Overview
10.2.3 Autolus Therapeutics Plc Adoptive Cellular ImmunOthersapy Product Market Performance
10.2.4 Autolus Therapeutics Plc Business Overview
10.2.5 Autolus Therapeutics Plc SWOT Analysis
10.2.6 Autolus Therapeutics Plc Recent Developments
10.3 Beijing Immunochina Medical Science and Technology Co Ltd
10.3.1 Beijing Immunochina Medical Science and Technology Co Ltd Basic Information
10.3.2 Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.3.3 Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.3.4 Beijing Immunochina Medical Science and Technology Co Ltd Business Overview
10.3.5 Beijing Immunochina Medical Science and Technology Co Ltd SWOT Analysis
10.3.6 Beijing Immunochina Medical Science and Technology Co Ltd Recent Developments
10.4 Bellicum Pharmaceuticals Inc
10.4.1 Bellicum Pharmaceuticals Inc Basic Information
10.4.2 Bellicum Pharmaceuticals Inc Adoptive Cellular ImmunOthersapy Product Overview
10.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.4.4 Bellicum Pharmaceuticals Inc Business Overview
10.4.5 Bellicum Pharmaceuticals Inc Recent Developments
10.5 Bristol-Myers Squibb Co
10.5.1 Bristol-Myers Squibb Co Basic Information
10.5.2 Bristol-Myers Squibb Co Adoptive Cellular ImmunOthersapy Product Overview
10.5.3 Bristol-Myers Squibb Co Adoptive Cellular ImmunOthersapy Product Market Performance
10.5.4 Bristol-Myers Squibb Co Business Overview
10.5.5 Bristol-Myers Squibb Co Recent Developments
10.6 bluebird bio Inc
10.6.1 bluebird bio Inc Basic Information
10.6.2 bluebird bio Inc Adoptive Cellular ImmunOthersapy Product Overview
10.6.3 bluebird bio Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.6.4 bluebird bio Inc Business Overview
10.6.5 bluebird bio Inc Recent Developments
10.7 CARsgen Therapeutics Ltd
10.7.1 CARsgen Therapeutics Ltd Basic Information
10.7.2 CARsgen Therapeutics Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.7.3 CARsgen Therapeutics Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.7.4 CARsgen Therapeutics Ltd Business Overview
10.7.5 CARsgen Therapeutics Ltd Recent Developments
10.8 Celgene Corp
10.8.1 Celgene Corp Basic Information
10.8.2 Celgene Corp Adoptive Cellular ImmunOthersapy Product Overview
10.8.3 Celgene Corp Adoptive Cellular ImmunOthersapy Product Market Performance
10.8.4 Celgene Corp Business Overview
10.8.5 Celgene Corp Recent Developments
10.9 Cell Medica Ltd
10.9.1 Cell Medica Ltd Basic Information
10.9.2 Cell Medica Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.9.3 Cell Medica Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.9.4 Cell Medica Ltd Business Overview
10.9.5 Cell Medica Ltd Recent Developments
10.10 Cellular Biomedicine Group Inc
10.10.1 Cellular Biomedicine Group Inc Basic Information
10.10.2 Cellular Biomedicine Group Inc Adoptive Cellular ImmunOthersapy Product Overview
10.10.3 Cellular Biomedicine Group Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.10.4 Cellular Biomedicine Group Inc Business Overview
10.10.5 Cellular Biomedicine Group Inc Recent Developments
10.11 Celularity Inc
10.11.1 Celularity Inc Basic Information
10.11.2 Celularity Inc Adoptive Cellular ImmunOthersapy Product Overview
10.11.3 Celularity Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.11.4 Celularity Inc Business Overview
10.11.5 Celularity Inc Recent Developments
10.12 Celyad SA
10.12.1 Celyad SA Basic Information
10.12.2 Celyad SA Adoptive Cellular ImmunOthersapy Product Overview
10.12.3 Celyad SA Adoptive Cellular ImmunOthersapy Product Market Performance
10.12.4 Celyad SA Business Overview
10.12.5 Celyad SA Recent Developments
10.13 Daiichi Sankyo Co Ltd
10.13.1 Daiichi Sankyo Co Ltd Basic Information
10.13.2 Daiichi Sankyo Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.13.4 Daiichi Sankyo Co Ltd Business Overview
10.13.5 Daiichi Sankyo Co Ltd Recent Developments
10.14 Fosun Pharmaceutical AG
10.14.1 Fosun Pharmaceutical AG Basic Information
10.14.2 Fosun Pharmaceutical AG Adoptive Cellular ImmunOthersapy Product Overview
10.14.3 Fosun Pharmaceutical AG Adoptive Cellular ImmunOthersapy Product Market Performance
10.14.4 Fosun Pharmaceutical AG Business Overview
10.14.5 Fosun Pharmaceutical AG Recent Developments
10.15 Gilead Sciences Inc
10.15.1 Gilead Sciences Inc Basic Information
10.15.2 Gilead Sciences Inc Adoptive Cellular ImmunOthersapy Product Overview
10.15.3 Gilead Sciences Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.15.4 Gilead Sciences Inc Business Overview
10.15.5 Gilead Sciences Inc Recent Developments
10.16 Guangzhou Anjie Biomedical Technology Co Ltd
10.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Basic Information
10.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
10.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
10.17 Hangzhou Converd Co Ltd
10.17.1 Hangzhou Converd Co Ltd Basic Information
10.17.2 Hangzhou Converd Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.17.3 Hangzhou Converd Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.17.4 Hangzhou Converd Co Ltd Business Overview
10.17.5 Hangzhou Converd Co Ltd Recent Developments
10.18 Hebei Senlang Biotechnology Inc Ltd
10.18.1 Hebei Senlang Biotechnology Inc Ltd Basic Information
10.18.2 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.18.4 Hebei Senlang Biotechnology Inc Ltd Business Overview
10.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Developments
10.19 HRAIN Biotechnology Co Ltd
10.19.1 HRAIN Biotechnology Co Ltd Basic Information
10.19.2 HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.19.4 HRAIN Biotechnology Co Ltd Business Overview
10.19.5 HRAIN Biotechnology Co Ltd Recent Developments
10.20 Juno Therapeutics Inc
10.20.1 Juno Therapeutics Inc Basic Information
10.20.2 Juno Therapeutics Inc Adoptive Cellular ImmunOthersapy Product Overview
10.20.3 Juno Therapeutics Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.20.4 Juno Therapeutics Inc Business Overview
10.20.5 Juno Therapeutics Inc Recent Developments
10.21 Kite Pharma Inc
10.21.1 Kite Pharma Inc Basic Information
10.21.2 Kite Pharma Inc Adoptive Cellular ImmunOthersapy Product Overview
10.21.3 Kite Pharma Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.21.4 Kite Pharma Inc Business Overview
10.21.5 Kite Pharma Inc Recent Developments
10.22 Nanjing Legend Biotech Co Ltd
10.22.1 Nanjing Legend Biotech Co Ltd Basic Information
10.22.2 Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.22.4 Nanjing Legend Biotech Co Ltd Business Overview
10.22.5 Nanjing Legend Biotech Co Ltd Recent Developments
10.23 NantKwest Inc
10.23.1 NantKwest Inc Basic Information
10.23.2 NantKwest Inc Adoptive Cellular ImmunOthersapy Product Overview
10.23.3 NantKwest Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.23.4 NantKwest Inc Business Overview
10.23.5 NantKwest Inc Recent Developments
10.24 Nkarta Inc
10.24.1 Nkarta Inc Basic Information
10.24.2 Nkarta Inc Adoptive Cellular ImmunOthersapy Product Overview
10.24.3 Nkarta Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.24.4 Nkarta Inc Business Overview
10.24.5 Nkarta Inc Recent Developments
10.25 Novartis AG
10.25.1 Novartis AG Basic Information
10.25.2 Novartis AG Adoptive Cellular ImmunOthersapy Product Overview
10.25.3 Novartis AG Adoptive Cellular ImmunOthersapy Product Market Performance
10.25.4 Novartis AG Business Overview
10.25.5 Novartis AG Recent Developments
10.26 Ono Pharmaceutical Co Ltd
10.26.1 Ono Pharmaceutical Co Ltd Basic Information
10.26.2 Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.26.4 Ono Pharmaceutical Co Ltd Business Overview
10.26.5 Ono Pharmaceutical Co Ltd Recent Developments
10.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
10.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information
10.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
10.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
10.28 Sorrento Therapeutics Inc
10.28.1 Sorrento Therapeutics Inc Basic Information
10.28.2 Sorrento Therapeutics Inc Adoptive Cellular ImmunOthersapy Product Overview
10.28.3 Sorrento Therapeutics Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.28.4 Sorrento Therapeutics Inc Business Overview
10.28.5 Sorrento Therapeutics Inc Recent Developments
10.29 Takara Bio Inc
10.29.1 Takara Bio Inc Basic Information
10.29.2 Takara Bio Inc Adoptive Cellular ImmunOthersapy Product Overview
10.29.3 Takara Bio Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.29.4 Takara Bio Inc Business Overview
10.29.5 Takara Bio Inc Recent Developments
11 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET FORECAST BY REGION
11.1 Global Adoptive Cellular ImmunOthersapy Market Size Forecast
11.2 Global Adoptive Cellular ImmunOthersapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Adoptive Cellular ImmunOthersapy Market Size Forecast by Country
11.2.3 Asia Pacific Adoptive Cellular ImmunOthersapy Market Size Forecast by Region
11.2.4 South America Adoptive Cellular ImmunOthersapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Adoptive Cellular ImmunOthersapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Adoptive Cellular ImmunOthersapy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Adoptive Cellular ImmunOthersapy by Type (2026-2033)
12.1.2 Global Adoptive Cellular ImmunOthersapy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Adoptive Cellular ImmunOthersapy by Type (2026-2033)
12.2 Global Adoptive Cellular ImmunOthersapy Market Forecast by Application (2026-2033)
12.2.1 Global Adoptive Cellular ImmunOthersapy Sales (K MT) Forecast by Application
12.2.2 Global Adoptive Cellular ImmunOthersapy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Adoptive Cellular ImmunOthersapy
1.2 Key Market Segments
1.2.1 Adoptive Cellular ImmunOthersapy Segment by Type
1.2.2 Adoptive Cellular ImmunOthersapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Adoptive Cellular ImmunOthersapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Adoptive Cellular ImmunOthersapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Adoptive Cellular ImmunOthersapy Product Life Cycle
3.3 Global Adoptive Cellular ImmunOthersapy Sales by Manufacturers (2020-2025)
3.4 Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Adoptive Cellular ImmunOthersapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Adoptive Cellular ImmunOthersapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Adoptive Cellular ImmunOthersapy Market Competitive Situation and Trends
3.8.1 Adoptive Cellular ImmunOthersapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Adoptive Cellular ImmunOthersapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ADOPTIVE CELLULAR IMMUNOTHERSAPY INDUSTRY CHAIN ANALYSIS
4.1 Adoptive Cellular ImmunOthersapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Adoptive Cellular ImmunOthersapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Adoptive Cellular ImmunOthersapy Market
5.7 ESG Ratings of Leading Companies
6 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adoptive Cellular ImmunOthersapy Sales Market Share by Type (2020-2025)
6.3 Global Adoptive Cellular ImmunOthersapy Market Size Market Share by Type (2020-2025)
6.4 Global Adoptive Cellular ImmunOthersapy Price by Type (2020-2025)
7 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adoptive Cellular ImmunOthersapy Market Sales by Application (2020-2025)
7.3 Global Adoptive Cellular ImmunOthersapy Market Size (M USD) by Application (2020-2025)
7.4 Global Adoptive Cellular ImmunOthersapy Sales Growth Rate by Application (2020-2025)
8 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET SALES BY REGION
8.1 Global Adoptive Cellular ImmunOthersapy Sales by Region
8.1.1 Global Adoptive Cellular ImmunOthersapy Sales by Region
8.1.2 Global Adoptive Cellular ImmunOthersapy Sales Market Share by Region
8.2 Global Adoptive Cellular ImmunOthersapy Market Size by Region
8.2.1 Global Adoptive Cellular ImmunOthersapy Market Size by Region
8.2.2 Global Adoptive Cellular ImmunOthersapy Market Size Market Share by Region
8.3 North America
8.3.1 North America Adoptive Cellular ImmunOthersapy Sales by Country
8.3.2 North America Adoptive Cellular ImmunOthersapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Adoptive Cellular ImmunOthersapy Sales by Country
8.4.2 Europe Adoptive Cellular ImmunOthersapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Adoptive Cellular ImmunOthersapy Sales by Region
8.5.2 Asia Pacific Adoptive Cellular ImmunOthersapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Adoptive Cellular ImmunOthersapy Sales by Country
8.6.2 South America Adoptive Cellular ImmunOthersapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Adoptive Cellular ImmunOthersapy Sales by Region
8.7.2 Middle East and Africa Adoptive Cellular ImmunOthersapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Adoptive Cellular ImmunOthersapy by Region(2020-2025)
9.2 Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Region (2020-2025)
9.3 Global Adoptive Cellular ImmunOthersapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Adoptive Cellular ImmunOthersapy Production
9.4.1 North America Adoptive Cellular ImmunOthersapy Production Growth Rate (2020-2025)
9.4.2 North America Adoptive Cellular ImmunOthersapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Adoptive Cellular ImmunOthersapy Production
9.5.1 Europe Adoptive Cellular ImmunOthersapy Production Growth Rate (2020-2025)
9.5.2 Europe Adoptive Cellular ImmunOthersapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Adoptive Cellular ImmunOthersapy Production (2020-2025)
9.6.1 Japan Adoptive Cellular ImmunOthersapy Production Growth Rate (2020-2025)
9.6.2 Japan Adoptive Cellular ImmunOthersapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Adoptive Cellular ImmunOthersapy Production (2020-2025)
9.7.1 China Adoptive Cellular ImmunOthersapy Production Growth Rate (2020-2025)
9.7.2 China Adoptive Cellular ImmunOthersapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Amgen Inc
10.1.1 Amgen Inc Basic Information
10.1.2 Amgen Inc Adoptive Cellular ImmunOthersapy Product Overview
10.1.3 Amgen Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.1.4 Amgen Inc Business Overview
10.1.5 Amgen Inc SWOT Analysis
10.1.6 Amgen Inc Recent Developments
10.2 Autolus Therapeutics Plc
10.2.1 Autolus Therapeutics Plc Basic Information
10.2.2 Autolus Therapeutics Plc Adoptive Cellular ImmunOthersapy Product Overview
10.2.3 Autolus Therapeutics Plc Adoptive Cellular ImmunOthersapy Product Market Performance
10.2.4 Autolus Therapeutics Plc Business Overview
10.2.5 Autolus Therapeutics Plc SWOT Analysis
10.2.6 Autolus Therapeutics Plc Recent Developments
10.3 Beijing Immunochina Medical Science and Technology Co Ltd
10.3.1 Beijing Immunochina Medical Science and Technology Co Ltd Basic Information
10.3.2 Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.3.3 Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.3.4 Beijing Immunochina Medical Science and Technology Co Ltd Business Overview
10.3.5 Beijing Immunochina Medical Science and Technology Co Ltd SWOT Analysis
10.3.6 Beijing Immunochina Medical Science and Technology Co Ltd Recent Developments
10.4 Bellicum Pharmaceuticals Inc
10.4.1 Bellicum Pharmaceuticals Inc Basic Information
10.4.2 Bellicum Pharmaceuticals Inc Adoptive Cellular ImmunOthersapy Product Overview
10.4.3 Bellicum Pharmaceuticals Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.4.4 Bellicum Pharmaceuticals Inc Business Overview
10.4.5 Bellicum Pharmaceuticals Inc Recent Developments
10.5 Bristol-Myers Squibb Co
10.5.1 Bristol-Myers Squibb Co Basic Information
10.5.2 Bristol-Myers Squibb Co Adoptive Cellular ImmunOthersapy Product Overview
10.5.3 Bristol-Myers Squibb Co Adoptive Cellular ImmunOthersapy Product Market Performance
10.5.4 Bristol-Myers Squibb Co Business Overview
10.5.5 Bristol-Myers Squibb Co Recent Developments
10.6 bluebird bio Inc
10.6.1 bluebird bio Inc Basic Information
10.6.2 bluebird bio Inc Adoptive Cellular ImmunOthersapy Product Overview
10.6.3 bluebird bio Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.6.4 bluebird bio Inc Business Overview
10.6.5 bluebird bio Inc Recent Developments
10.7 CARsgen Therapeutics Ltd
10.7.1 CARsgen Therapeutics Ltd Basic Information
10.7.2 CARsgen Therapeutics Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.7.3 CARsgen Therapeutics Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.7.4 CARsgen Therapeutics Ltd Business Overview
10.7.5 CARsgen Therapeutics Ltd Recent Developments
10.8 Celgene Corp
10.8.1 Celgene Corp Basic Information
10.8.2 Celgene Corp Adoptive Cellular ImmunOthersapy Product Overview
10.8.3 Celgene Corp Adoptive Cellular ImmunOthersapy Product Market Performance
10.8.4 Celgene Corp Business Overview
10.8.5 Celgene Corp Recent Developments
10.9 Cell Medica Ltd
10.9.1 Cell Medica Ltd Basic Information
10.9.2 Cell Medica Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.9.3 Cell Medica Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.9.4 Cell Medica Ltd Business Overview
10.9.5 Cell Medica Ltd Recent Developments
10.10 Cellular Biomedicine Group Inc
10.10.1 Cellular Biomedicine Group Inc Basic Information
10.10.2 Cellular Biomedicine Group Inc Adoptive Cellular ImmunOthersapy Product Overview
10.10.3 Cellular Biomedicine Group Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.10.4 Cellular Biomedicine Group Inc Business Overview
10.10.5 Cellular Biomedicine Group Inc Recent Developments
10.11 Celularity Inc
10.11.1 Celularity Inc Basic Information
10.11.2 Celularity Inc Adoptive Cellular ImmunOthersapy Product Overview
10.11.3 Celularity Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.11.4 Celularity Inc Business Overview
10.11.5 Celularity Inc Recent Developments
10.12 Celyad SA
10.12.1 Celyad SA Basic Information
10.12.2 Celyad SA Adoptive Cellular ImmunOthersapy Product Overview
10.12.3 Celyad SA Adoptive Cellular ImmunOthersapy Product Market Performance
10.12.4 Celyad SA Business Overview
10.12.5 Celyad SA Recent Developments
10.13 Daiichi Sankyo Co Ltd
10.13.1 Daiichi Sankyo Co Ltd Basic Information
10.13.2 Daiichi Sankyo Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.13.3 Daiichi Sankyo Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.13.4 Daiichi Sankyo Co Ltd Business Overview
10.13.5 Daiichi Sankyo Co Ltd Recent Developments
10.14 Fosun Pharmaceutical AG
10.14.1 Fosun Pharmaceutical AG Basic Information
10.14.2 Fosun Pharmaceutical AG Adoptive Cellular ImmunOthersapy Product Overview
10.14.3 Fosun Pharmaceutical AG Adoptive Cellular ImmunOthersapy Product Market Performance
10.14.4 Fosun Pharmaceutical AG Business Overview
10.14.5 Fosun Pharmaceutical AG Recent Developments
10.15 Gilead Sciences Inc
10.15.1 Gilead Sciences Inc Basic Information
10.15.2 Gilead Sciences Inc Adoptive Cellular ImmunOthersapy Product Overview
10.15.3 Gilead Sciences Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.15.4 Gilead Sciences Inc Business Overview
10.15.5 Gilead Sciences Inc Recent Developments
10.16 Guangzhou Anjie Biomedical Technology Co Ltd
10.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Basic Information
10.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
10.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
10.17 Hangzhou Converd Co Ltd
10.17.1 Hangzhou Converd Co Ltd Basic Information
10.17.2 Hangzhou Converd Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.17.3 Hangzhou Converd Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.17.4 Hangzhou Converd Co Ltd Business Overview
10.17.5 Hangzhou Converd Co Ltd Recent Developments
10.18 Hebei Senlang Biotechnology Inc Ltd
10.18.1 Hebei Senlang Biotechnology Inc Ltd Basic Information
10.18.2 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.18.3 Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.18.4 Hebei Senlang Biotechnology Inc Ltd Business Overview
10.18.5 Hebei Senlang Biotechnology Inc Ltd Recent Developments
10.19 HRAIN Biotechnology Co Ltd
10.19.1 HRAIN Biotechnology Co Ltd Basic Information
10.19.2 HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.19.3 HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.19.4 HRAIN Biotechnology Co Ltd Business Overview
10.19.5 HRAIN Biotechnology Co Ltd Recent Developments
10.20 Juno Therapeutics Inc
10.20.1 Juno Therapeutics Inc Basic Information
10.20.2 Juno Therapeutics Inc Adoptive Cellular ImmunOthersapy Product Overview
10.20.3 Juno Therapeutics Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.20.4 Juno Therapeutics Inc Business Overview
10.20.5 Juno Therapeutics Inc Recent Developments
10.21 Kite Pharma Inc
10.21.1 Kite Pharma Inc Basic Information
10.21.2 Kite Pharma Inc Adoptive Cellular ImmunOthersapy Product Overview
10.21.3 Kite Pharma Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.21.4 Kite Pharma Inc Business Overview
10.21.5 Kite Pharma Inc Recent Developments
10.22 Nanjing Legend Biotech Co Ltd
10.22.1 Nanjing Legend Biotech Co Ltd Basic Information
10.22.2 Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.22.3 Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.22.4 Nanjing Legend Biotech Co Ltd Business Overview
10.22.5 Nanjing Legend Biotech Co Ltd Recent Developments
10.23 NantKwest Inc
10.23.1 NantKwest Inc Basic Information
10.23.2 NantKwest Inc Adoptive Cellular ImmunOthersapy Product Overview
10.23.3 NantKwest Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.23.4 NantKwest Inc Business Overview
10.23.5 NantKwest Inc Recent Developments
10.24 Nkarta Inc
10.24.1 Nkarta Inc Basic Information
10.24.2 Nkarta Inc Adoptive Cellular ImmunOthersapy Product Overview
10.24.3 Nkarta Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.24.4 Nkarta Inc Business Overview
10.24.5 Nkarta Inc Recent Developments
10.25 Novartis AG
10.25.1 Novartis AG Basic Information
10.25.2 Novartis AG Adoptive Cellular ImmunOthersapy Product Overview
10.25.3 Novartis AG Adoptive Cellular ImmunOthersapy Product Market Performance
10.25.4 Novartis AG Business Overview
10.25.5 Novartis AG Recent Developments
10.26 Ono Pharmaceutical Co Ltd
10.26.1 Ono Pharmaceutical Co Ltd Basic Information
10.26.2 Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.26.3 Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.26.4 Ono Pharmaceutical Co Ltd Business Overview
10.26.5 Ono Pharmaceutical Co Ltd Recent Developments
10.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
10.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information
10.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
10.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Market Performance
10.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
10.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
10.28 Sorrento Therapeutics Inc
10.28.1 Sorrento Therapeutics Inc Basic Information
10.28.2 Sorrento Therapeutics Inc Adoptive Cellular ImmunOthersapy Product Overview
10.28.3 Sorrento Therapeutics Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.28.4 Sorrento Therapeutics Inc Business Overview
10.28.5 Sorrento Therapeutics Inc Recent Developments
10.29 Takara Bio Inc
10.29.1 Takara Bio Inc Basic Information
10.29.2 Takara Bio Inc Adoptive Cellular ImmunOthersapy Product Overview
10.29.3 Takara Bio Inc Adoptive Cellular ImmunOthersapy Product Market Performance
10.29.4 Takara Bio Inc Business Overview
10.29.5 Takara Bio Inc Recent Developments
11 ADOPTIVE CELLULAR IMMUNOTHERSAPY MARKET FORECAST BY REGION
11.1 Global Adoptive Cellular ImmunOthersapy Market Size Forecast
11.2 Global Adoptive Cellular ImmunOthersapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Adoptive Cellular ImmunOthersapy Market Size Forecast by Country
11.2.3 Asia Pacific Adoptive Cellular ImmunOthersapy Market Size Forecast by Region
11.2.4 South America Adoptive Cellular ImmunOthersapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Adoptive Cellular ImmunOthersapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Adoptive Cellular ImmunOthersapy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Adoptive Cellular ImmunOthersapy by Type (2026-2033)
12.1.2 Global Adoptive Cellular ImmunOthersapy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Adoptive Cellular ImmunOthersapy by Type (2026-2033)
12.2 Global Adoptive Cellular ImmunOthersapy Market Forecast by Application (2026-2033)
12.2.1 Global Adoptive Cellular ImmunOthersapy Sales (K MT) Forecast by Application
12.2.2 Global Adoptive Cellular ImmunOthersapy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adoptive Cellular ImmunOthersapy Market Size Comparison by Region (M USD)
Table 5. Global Adoptive Cellular ImmunOthersapy Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Adoptive Cellular ImmunOthersapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Adoptive Cellular ImmunOthersapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cellular ImmunOthersapy as of 2024)
Table 10. Global Market Adoptive Cellular ImmunOthersapy Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Adoptive Cellular ImmunOthersapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Adoptive Cellular ImmunOthersapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Adoptive Cellular ImmunOthersapy Sales by Type (K MT)
Table 26. Global Adoptive Cellular ImmunOthersapy Market Size by Type (M USD)
Table 27. Global Adoptive Cellular ImmunOthersapy Sales (K MT) by Type (2020-2025)
Table 28. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Type (2020-2025)
Table 29. Global Adoptive Cellular ImmunOthersapy Market Size (M USD) by Type (2020-2025)
Table 30. Global Adoptive Cellular ImmunOthersapy Market Size Share by Type (2020-2025)
Table 31. Global Adoptive Cellular ImmunOthersapy Price (USD/MT) by Type (2020-2025)
Table 32. Global Adoptive Cellular ImmunOthersapy Sales (K MT) by Application
Table 33. Global Adoptive Cellular ImmunOthersapy Market Size by Application
Table 34. Global Adoptive Cellular ImmunOthersapy Sales by Application (2020-2025) & (K MT)
Table 35. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Application (2020-2025)
Table 36. Global Adoptive Cellular ImmunOthersapy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Adoptive Cellular ImmunOthersapy Market Share by Application (2020-2025)
Table 38. Global Adoptive Cellular ImmunOthersapy Sales Growth Rate by Application (2020-2025)
Table 39. Global Adoptive Cellular ImmunOthersapy Sales by Region (2020-2025) & (K MT)
Table 40. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Region (2020-2025)
Table 41. Global Adoptive Cellular ImmunOthersapy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Adoptive Cellular ImmunOthersapy Market Size Market Share by Region (2020-2025)
Table 43. North America Adoptive Cellular ImmunOthersapy Sales by Country (2020-2025) & (K MT)
Table 44. North America Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Adoptive Cellular ImmunOthersapy Sales by Country (2020-2025) & (K MT)
Table 46. Europe Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Adoptive Cellular ImmunOthersapy Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Adoptive Cellular ImmunOthersapy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Adoptive Cellular ImmunOthersapy Sales by Country (2020-2025) & (K MT)
Table 50. South America Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Adoptive Cellular ImmunOthersapy Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Adoptive Cellular ImmunOthersapy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Adoptive Cellular ImmunOthersapy Production (K MT) by Region(2020-2025)
Table 54. Global Adoptive Cellular ImmunOthersapy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Region (2020-2025)
Table 56. Global Adoptive Cellular ImmunOthersapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. North America Adoptive Cellular ImmunOthersapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Europe Adoptive Cellular ImmunOthersapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. Japan Adoptive Cellular ImmunOthersapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. China Adoptive Cellular ImmunOthersapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 61. Amgen Inc Basic Information
Table 62. Amgen Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 63. Amgen Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 64. Amgen Inc Business Overview
Table 65. Amgen Inc SWOT Analysis
Table 66. Amgen Inc Recent Developments
Table 67. Autolus Therapeutics Plc Basic Information
Table 68. Autolus Therapeutics Plc Adoptive Cellular ImmunOthersapy Product Overview
Table 69. Autolus Therapeutics Plc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. Autolus Therapeutics Plc Business Overview
Table 71. Autolus Therapeutics Plc SWOT Analysis
Table 72. Autolus Therapeutics Plc Recent Developments
Table 73. Beijing Immunochina Medical Science and Technology Co Ltd Basic Information
Table 74. Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 75. Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. Beijing Immunochina Medical Science and Technology Co Ltd Business Overview
Table 77. Beijing Immunochina Medical Science and Technology Co Ltd SWOT Analysis
Table 78. Beijing Immunochina Medical Science and Technology Co Ltd Recent Developments
Table 79. Bellicum Pharmaceuticals Inc Basic Information
Table 80. Bellicum Pharmaceuticals Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 81. Bellicum Pharmaceuticals Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 82. Bellicum Pharmaceuticals Inc Business Overview
Table 83. Bellicum Pharmaceuticals Inc Recent Developments
Table 84. Bristol-Myers Squibb Co Basic Information
Table 85. Bristol-Myers Squibb Co Adoptive Cellular ImmunOthersapy Product Overview
Table 86. Bristol-Myers Squibb Co Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. Bristol-Myers Squibb Co Business Overview
Table 88. Bristol-Myers Squibb Co Recent Developments
Table 89. bluebird bio Inc Basic Information
Table 90. bluebird bio Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 91. bluebird bio Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 92. bluebird bio Inc Business Overview
Table 93. bluebird bio Inc Recent Developments
Table 94. CARsgen Therapeutics Ltd Basic Information
Table 95. CARsgen Therapeutics Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 96. CARsgen Therapeutics Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 97. CARsgen Therapeutics Ltd Business Overview
Table 98. CARsgen Therapeutics Ltd Recent Developments
Table 99. Celgene Corp Basic Information
Table 100. Celgene Corp Adoptive Cellular ImmunOthersapy Product Overview
Table 101. Celgene Corp Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Celgene Corp Business Overview
Table 103. Celgene Corp Recent Developments
Table 104. Cell Medica Ltd Basic Information
Table 105. Cell Medica Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 106. Cell Medica Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Cell Medica Ltd Business Overview
Table 108. Cell Medica Ltd Recent Developments
Table 109. Cellular Biomedicine Group Inc Basic Information
Table 110. Cellular Biomedicine Group Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 111. Cellular Biomedicine Group Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Cellular Biomedicine Group Inc Business Overview
Table 113. Cellular Biomedicine Group Inc Recent Developments
Table 114. Celularity Inc Basic Information
Table 115. Celularity Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 116. Celularity Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Celularity Inc Business Overview
Table 118. Celularity Inc Recent Developments
Table 119. Celyad SA Basic Information
Table 120. Celyad SA Adoptive Cellular ImmunOthersapy Product Overview
Table 121. Celyad SA Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Celyad SA Business Overview
Table 123. Celyad SA Recent Developments
Table 124. Daiichi Sankyo Co Ltd Basic Information
Table 125. Daiichi Sankyo Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 126. Daiichi Sankyo Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Daiichi Sankyo Co Ltd Business Overview
Table 128. Daiichi Sankyo Co Ltd Recent Developments
Table 129. Fosun Pharmaceutical AG Basic Information
Table 130. Fosun Pharmaceutical AG Adoptive Cellular ImmunOthersapy Product Overview
Table 131. Fosun Pharmaceutical AG Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Fosun Pharmaceutical AG Business Overview
Table 133. Fosun Pharmaceutical AG Recent Developments
Table 134. Gilead Sciences Inc Basic Information
Table 135. Gilead Sciences Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 136. Gilead Sciences Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Gilead Sciences Inc Business Overview
Table 138. Gilead Sciences Inc Recent Developments
Table 139. Guangzhou Anjie Biomedical Technology Co Ltd Basic Information
Table 140. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 141. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 143. Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
Table 144. Hangzhou Converd Co Ltd Basic Information
Table 145. Hangzhou Converd Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 146. Hangzhou Converd Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Hangzhou Converd Co Ltd Business Overview
Table 148. Hangzhou Converd Co Ltd Recent Developments
Table 149. Hebei Senlang Biotechnology Inc Ltd Basic Information
Table 150. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 151. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 153. Hebei Senlang Biotechnology Inc Ltd Recent Developments
Table 154. HRAIN Biotechnology Co Ltd Basic Information
Table 155. HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 156. HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. HRAIN Biotechnology Co Ltd Business Overview
Table 158. HRAIN Biotechnology Co Ltd Recent Developments
Table 159. Juno Therapeutics Inc Basic Information
Table 160. Juno Therapeutics Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 161. Juno Therapeutics Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Juno Therapeutics Inc Business Overview
Table 163. Juno Therapeutics Inc Recent Developments
Table 164. Kite Pharma Inc Basic Information
Table 165. Kite Pharma Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 166. Kite Pharma Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Kite Pharma Inc Business Overview
Table 168. Kite Pharma Inc Recent Developments
Table 169. Nanjing Legend Biotech Co Ltd Basic Information
Table 170. Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 171. Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Nanjing Legend Biotech Co Ltd Business Overview
Table 173. Nanjing Legend Biotech Co Ltd Recent Developments
Table 174. NantKwest Inc Basic Information
Table 175. NantKwest Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 176. NantKwest Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. NantKwest Inc Business Overview
Table 178. NantKwest Inc Recent Developments
Table 179. Nkarta Inc Basic Information
Table 180. Nkarta Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 181. Nkarta Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Nkarta Inc Business Overview
Table 183. Nkarta Inc Recent Developments
Table 184. Novartis AG Basic Information
Table 185. Novartis AG Adoptive Cellular ImmunOthersapy Product Overview
Table 186. Novartis AG Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. Novartis AG Business Overview
Table 188. Novartis AG Recent Developments
Table 189. Ono Pharmaceutical Co Ltd Basic Information
Table 190. Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 191. Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. Ono Pharmaceutical Co Ltd Business Overview
Table 193. Ono Pharmaceutical Co Ltd Recent Developments
Table 194. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information
Table 195. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 196. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 197. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 198. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
Table 199. Sorrento Therapeutics Inc Basic Information
Table 200. Sorrento Therapeutics Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 201. Sorrento Therapeutics Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 202. Sorrento Therapeutics Inc Business Overview
Table 203. Sorrento Therapeutics Inc Recent Developments
Table 204. Takara Bio Inc Basic Information
Table 205. Takara Bio Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 206. Takara Bio Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 207. Takara Bio Inc Business Overview
Table 208. Takara Bio Inc Recent Developments
Table 209. Global Adoptive Cellular ImmunOthersapy Sales Forecast by Region (2026-2033) & (K MT)
Table 210. Global Adoptive Cellular ImmunOthersapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 211. North America Adoptive Cellular ImmunOthersapy Sales Forecast by Country (2026-2033) & (K MT)
Table 212. North America Adoptive Cellular ImmunOthersapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 213. Europe Adoptive Cellular ImmunOthersapy Sales Forecast by Country (2026-2033) & (K MT)
Table 214. Europe Adoptive Cellular ImmunOthersapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 215. Asia Pacific Adoptive Cellular ImmunOthersapy Sales Forecast by Region (2026-2033) & (K MT)
Table 216. Asia Pacific Adoptive Cellular ImmunOthersapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 217. South America Adoptive Cellular ImmunOthersapy Sales Forecast by Country (2026-2033) & (K MT)
Table 218. South America Adoptive Cellular ImmunOthersapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 219. Middle East and Africa Adoptive Cellular ImmunOthersapy Sales Forecast by Country (2026-2033) & (Units)
Table 220. Middle East and Africa Adoptive Cellular ImmunOthersapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 221. Global Adoptive Cellular ImmunOthersapy Sales Forecast by Type (2026-2033) & (K MT)
Table 222. Global Adoptive Cellular ImmunOthersapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 223. Global Adoptive Cellular ImmunOthersapy Price Forecast by Type (2026-2033) & (USD/MT)
Table 224. Global Adoptive Cellular ImmunOthersapy Sales (K MT) Forecast by Application (2026-2033)
Table 225. Global Adoptive Cellular ImmunOthersapy Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adoptive Cellular ImmunOthersapy Market Size Comparison by Region (M USD)
Table 5. Global Adoptive Cellular ImmunOthersapy Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Adoptive Cellular ImmunOthersapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Adoptive Cellular ImmunOthersapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cellular ImmunOthersapy as of 2024)
Table 10. Global Market Adoptive Cellular ImmunOthersapy Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Adoptive Cellular ImmunOthersapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Adoptive Cellular ImmunOthersapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Adoptive Cellular ImmunOthersapy Sales by Type (K MT)
Table 26. Global Adoptive Cellular ImmunOthersapy Market Size by Type (M USD)
Table 27. Global Adoptive Cellular ImmunOthersapy Sales (K MT) by Type (2020-2025)
Table 28. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Type (2020-2025)
Table 29. Global Adoptive Cellular ImmunOthersapy Market Size (M USD) by Type (2020-2025)
Table 30. Global Adoptive Cellular ImmunOthersapy Market Size Share by Type (2020-2025)
Table 31. Global Adoptive Cellular ImmunOthersapy Price (USD/MT) by Type (2020-2025)
Table 32. Global Adoptive Cellular ImmunOthersapy Sales (K MT) by Application
Table 33. Global Adoptive Cellular ImmunOthersapy Market Size by Application
Table 34. Global Adoptive Cellular ImmunOthersapy Sales by Application (2020-2025) & (K MT)
Table 35. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Application (2020-2025)
Table 36. Global Adoptive Cellular ImmunOthersapy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Adoptive Cellular ImmunOthersapy Market Share by Application (2020-2025)
Table 38. Global Adoptive Cellular ImmunOthersapy Sales Growth Rate by Application (2020-2025)
Table 39. Global Adoptive Cellular ImmunOthersapy Sales by Region (2020-2025) & (K MT)
Table 40. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Region (2020-2025)
Table 41. Global Adoptive Cellular ImmunOthersapy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Adoptive Cellular ImmunOthersapy Market Size Market Share by Region (2020-2025)
Table 43. North America Adoptive Cellular ImmunOthersapy Sales by Country (2020-2025) & (K MT)
Table 44. North America Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Adoptive Cellular ImmunOthersapy Sales by Country (2020-2025) & (K MT)
Table 46. Europe Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Adoptive Cellular ImmunOthersapy Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Adoptive Cellular ImmunOthersapy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Adoptive Cellular ImmunOthersapy Sales by Country (2020-2025) & (K MT)
Table 50. South America Adoptive Cellular ImmunOthersapy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Adoptive Cellular ImmunOthersapy Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Adoptive Cellular ImmunOthersapy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Adoptive Cellular ImmunOthersapy Production (K MT) by Region(2020-2025)
Table 54. Global Adoptive Cellular ImmunOthersapy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Adoptive Cellular ImmunOthersapy Revenue Market Share by Region (2020-2025)
Table 56. Global Adoptive Cellular ImmunOthersapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 57. North America Adoptive Cellular ImmunOthersapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 58. Europe Adoptive Cellular ImmunOthersapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 59. Japan Adoptive Cellular ImmunOthersapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 60. China Adoptive Cellular ImmunOthersapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 61. Amgen Inc Basic Information
Table 62. Amgen Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 63. Amgen Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 64. Amgen Inc Business Overview
Table 65. Amgen Inc SWOT Analysis
Table 66. Amgen Inc Recent Developments
Table 67. Autolus Therapeutics Plc Basic Information
Table 68. Autolus Therapeutics Plc Adoptive Cellular ImmunOthersapy Product Overview
Table 69. Autolus Therapeutics Plc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 70. Autolus Therapeutics Plc Business Overview
Table 71. Autolus Therapeutics Plc SWOT Analysis
Table 72. Autolus Therapeutics Plc Recent Developments
Table 73. Beijing Immunochina Medical Science and Technology Co Ltd Basic Information
Table 74. Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 75. Beijing Immunochina Medical Science and Technology Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 76. Beijing Immunochina Medical Science and Technology Co Ltd Business Overview
Table 77. Beijing Immunochina Medical Science and Technology Co Ltd SWOT Analysis
Table 78. Beijing Immunochina Medical Science and Technology Co Ltd Recent Developments
Table 79. Bellicum Pharmaceuticals Inc Basic Information
Table 80. Bellicum Pharmaceuticals Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 81. Bellicum Pharmaceuticals Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 82. Bellicum Pharmaceuticals Inc Business Overview
Table 83. Bellicum Pharmaceuticals Inc Recent Developments
Table 84. Bristol-Myers Squibb Co Basic Information
Table 85. Bristol-Myers Squibb Co Adoptive Cellular ImmunOthersapy Product Overview
Table 86. Bristol-Myers Squibb Co Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. Bristol-Myers Squibb Co Business Overview
Table 88. Bristol-Myers Squibb Co Recent Developments
Table 89. bluebird bio Inc Basic Information
Table 90. bluebird bio Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 91. bluebird bio Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 92. bluebird bio Inc Business Overview
Table 93. bluebird bio Inc Recent Developments
Table 94. CARsgen Therapeutics Ltd Basic Information
Table 95. CARsgen Therapeutics Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 96. CARsgen Therapeutics Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 97. CARsgen Therapeutics Ltd Business Overview
Table 98. CARsgen Therapeutics Ltd Recent Developments
Table 99. Celgene Corp Basic Information
Table 100. Celgene Corp Adoptive Cellular ImmunOthersapy Product Overview
Table 101. Celgene Corp Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 102. Celgene Corp Business Overview
Table 103. Celgene Corp Recent Developments
Table 104. Cell Medica Ltd Basic Information
Table 105. Cell Medica Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 106. Cell Medica Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 107. Cell Medica Ltd Business Overview
Table 108. Cell Medica Ltd Recent Developments
Table 109. Cellular Biomedicine Group Inc Basic Information
Table 110. Cellular Biomedicine Group Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 111. Cellular Biomedicine Group Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 112. Cellular Biomedicine Group Inc Business Overview
Table 113. Cellular Biomedicine Group Inc Recent Developments
Table 114. Celularity Inc Basic Information
Table 115. Celularity Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 116. Celularity Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 117. Celularity Inc Business Overview
Table 118. Celularity Inc Recent Developments
Table 119. Celyad SA Basic Information
Table 120. Celyad SA Adoptive Cellular ImmunOthersapy Product Overview
Table 121. Celyad SA Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Celyad SA Business Overview
Table 123. Celyad SA Recent Developments
Table 124. Daiichi Sankyo Co Ltd Basic Information
Table 125. Daiichi Sankyo Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 126. Daiichi Sankyo Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Daiichi Sankyo Co Ltd Business Overview
Table 128. Daiichi Sankyo Co Ltd Recent Developments
Table 129. Fosun Pharmaceutical AG Basic Information
Table 130. Fosun Pharmaceutical AG Adoptive Cellular ImmunOthersapy Product Overview
Table 131. Fosun Pharmaceutical AG Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Fosun Pharmaceutical AG Business Overview
Table 133. Fosun Pharmaceutical AG Recent Developments
Table 134. Gilead Sciences Inc Basic Information
Table 135. Gilead Sciences Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 136. Gilead Sciences Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Gilead Sciences Inc Business Overview
Table 138. Gilead Sciences Inc Recent Developments
Table 139. Guangzhou Anjie Biomedical Technology Co Ltd Basic Information
Table 140. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 141. Guangzhou Anjie Biomedical Technology Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. Guangzhou Anjie Biomedical Technology Co Ltd Business Overview
Table 143. Guangzhou Anjie Biomedical Technology Co Ltd Recent Developments
Table 144. Hangzhou Converd Co Ltd Basic Information
Table 145. Hangzhou Converd Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 146. Hangzhou Converd Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. Hangzhou Converd Co Ltd Business Overview
Table 148. Hangzhou Converd Co Ltd Recent Developments
Table 149. Hebei Senlang Biotechnology Inc Ltd Basic Information
Table 150. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 151. Hebei Senlang Biotechnology Inc Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Hebei Senlang Biotechnology Inc Ltd Business Overview
Table 153. Hebei Senlang Biotechnology Inc Ltd Recent Developments
Table 154. HRAIN Biotechnology Co Ltd Basic Information
Table 155. HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 156. HRAIN Biotechnology Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. HRAIN Biotechnology Co Ltd Business Overview
Table 158. HRAIN Biotechnology Co Ltd Recent Developments
Table 159. Juno Therapeutics Inc Basic Information
Table 160. Juno Therapeutics Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 161. Juno Therapeutics Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. Juno Therapeutics Inc Business Overview
Table 163. Juno Therapeutics Inc Recent Developments
Table 164. Kite Pharma Inc Basic Information
Table 165. Kite Pharma Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 166. Kite Pharma Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Kite Pharma Inc Business Overview
Table 168. Kite Pharma Inc Recent Developments
Table 169. Nanjing Legend Biotech Co Ltd Basic Information
Table 170. Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 171. Nanjing Legend Biotech Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 172. Nanjing Legend Biotech Co Ltd Business Overview
Table 173. Nanjing Legend Biotech Co Ltd Recent Developments
Table 174. NantKwest Inc Basic Information
Table 175. NantKwest Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 176. NantKwest Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 177. NantKwest Inc Business Overview
Table 178. NantKwest Inc Recent Developments
Table 179. Nkarta Inc Basic Information
Table 180. Nkarta Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 181. Nkarta Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 182. Nkarta Inc Business Overview
Table 183. Nkarta Inc Recent Developments
Table 184. Novartis AG Basic Information
Table 185. Novartis AG Adoptive Cellular ImmunOthersapy Product Overview
Table 186. Novartis AG Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 187. Novartis AG Business Overview
Table 188. Novartis AG Recent Developments
Table 189. Ono Pharmaceutical Co Ltd Basic Information
Table 190. Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 191. Ono Pharmaceutical Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 192. Ono Pharmaceutical Co Ltd Business Overview
Table 193. Ono Pharmaceutical Co Ltd Recent Developments
Table 194. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Basic Information
Table 195. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunOthersapy Product Overview
Table 196. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 197. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Business Overview
Table 198. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Recent Developments
Table 199. Sorrento Therapeutics Inc Basic Information
Table 200. Sorrento Therapeutics Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 201. Sorrento Therapeutics Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 202. Sorrento Therapeutics Inc Business Overview
Table 203. Sorrento Therapeutics Inc Recent Developments
Table 204. Takara Bio Inc Basic Information
Table 205. Takara Bio Inc Adoptive Cellular ImmunOthersapy Product Overview
Table 206. Takara Bio Inc Adoptive Cellular ImmunOthersapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 207. Takara Bio Inc Business Overview
Table 208. Takara Bio Inc Recent Developments
Table 209. Global Adoptive Cellular ImmunOthersapy Sales Forecast by Region (2026-2033) & (K MT)
Table 210. Global Adoptive Cellular ImmunOthersapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 211. North America Adoptive Cellular ImmunOthersapy Sales Forecast by Country (2026-2033) & (K MT)
Table 212. North America Adoptive Cellular ImmunOthersapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 213. Europe Adoptive Cellular ImmunOthersapy Sales Forecast by Country (2026-2033) & (K MT)
Table 214. Europe Adoptive Cellular ImmunOthersapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 215. Asia Pacific Adoptive Cellular ImmunOthersapy Sales Forecast by Region (2026-2033) & (K MT)
Table 216. Asia Pacific Adoptive Cellular ImmunOthersapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 217. South America Adoptive Cellular ImmunOthersapy Sales Forecast by Country (2026-2033) & (K MT)
Table 218. South America Adoptive Cellular ImmunOthersapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 219. Middle East and Africa Adoptive Cellular ImmunOthersapy Sales Forecast by Country (2026-2033) & (Units)
Table 220. Middle East and Africa Adoptive Cellular ImmunOthersapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 221. Global Adoptive Cellular ImmunOthersapy Sales Forecast by Type (2026-2033) & (K MT)
Table 222. Global Adoptive Cellular ImmunOthersapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 223. Global Adoptive Cellular ImmunOthersapy Price Forecast by Type (2026-2033) & (USD/MT)
Table 224. Global Adoptive Cellular ImmunOthersapy Sales (K MT) Forecast by Application (2026-2033)
Table 225. Global Adoptive Cellular ImmunOthersapy Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Adoptive Cellular ImmunOthersapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adoptive Cellular ImmunOthersapy Market Size (M USD), 2024-2033
Figure 5. Global Adoptive Cellular ImmunOthersapy Market Size (M USD) (2020-2033)
Figure 6. Global Adoptive Cellular ImmunOthersapy Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Adoptive Cellular ImmunOthersapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Adoptive Cellular ImmunOthersapy Product Life Cycle
Figure 13. Adoptive Cellular ImmunOthersapy Sales Share by Manufacturers in 2024
Figure 14. Global Adoptive Cellular ImmunOthersapy Revenue Share by Manufacturers in 2024
Figure 15. Adoptive Cellular ImmunOthersapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Adoptive Cellular ImmunOthersapy Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Adoptive Cellular ImmunOthersapy Revenue in 2024
Figure 18. Industry Chain Map of Adoptive Cellular ImmunOthersapy
Figure 19. Global Adoptive Cellular ImmunOthersapy Market PEST Analysis
Figure 20. Global Adoptive Cellular ImmunOthersapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Adoptive Cellular ImmunOthersapy Market Share by Type
Figure 27. Sales Market Share of Adoptive Cellular ImmunOthersapy by Type (2020-2025)
Figure 28. Sales Market Share of Adoptive Cellular ImmunOthersapy by Type in 2024
Figure 29. Market Size Share of Adoptive Cellular ImmunOthersapy by Type (2020-2025)
Figure 30. Market Size Share of Adoptive Cellular ImmunOthersapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Adoptive Cellular ImmunOthersapy Market Share by Application
Figure 33. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Application (2020-2025)
Figure 34. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Application in 2024
Figure 35. Global Adoptive Cellular ImmunOthersapy Market Share by Application (2020-2025)
Figure 36. Global Adoptive Cellular ImmunOthersapy Market Share by Application in 2024
Figure 37. Global Adoptive Cellular ImmunOthersapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Region (2020-2025)
Figure 39. Global Adoptive Cellular ImmunOthersapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Adoptive Cellular ImmunOthersapy Sales Market Share by Country in 2024
Figure 43. North America Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Adoptive Cellular ImmunOthersapy Market Size Market Share by Country in 2024
Figure 45. U.S. Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Adoptive Cellular ImmunOthersapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Adoptive Cellular ImmunOthersapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Adoptive Cellular ImmunOthersapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Adoptive Cellular ImmunOthersapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Adoptive Cellular ImmunOthersapy Sales Market Share by Country in 2024
Figure 53. Europe Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Adoptive Cellular ImmunOthersapy Market Size Market Share by Country in 2024
Figure 55. Germany Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Adoptive Cellular ImmunOthersapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Adoptive Cellular ImmunOthersapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Adoptive Cellular ImmunOthersapy Market Size Market Share by Region in 2024
Figure 68. China Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Adoptive Cellular ImmunOthersapy Sales and Growth Rate (K MT)
Figure 79. South America Adoptive Cellular ImmunOthersapy Sales Market Share by Country in 2024
Figure 80. South America Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (M USD)
Figure 81. South America Adoptive Cellular ImmunOthersapy Market Size Market Share by Country in 2024
Figure 82. Brazil Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Adoptive Cellular ImmunOthersapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Adoptive Cellular ImmunOthersapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Adoptive Cellular ImmunOthersapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Adoptive Cellular ImmunOthersapy Production Market Share by Region (2020-2025)
Figure 103. North America Adoptive Cellular ImmunOthersapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Adoptive Cellular ImmunOthersapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Adoptive Cellular ImmunOthersapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China Adoptive Cellular ImmunOthersapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Adoptive Cellular ImmunOthersapy Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Adoptive Cellular ImmunOthersapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Adoptive Cellular ImmunOthersapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Adoptive Cellular ImmunOthersapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Adoptive Cellular ImmunOthersapy Sales Forecast by Application (2026-2033)
Figure 112. Global Adoptive Cellular ImmunOthersapy Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Adoptive Cellular ImmunOthersapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adoptive Cellular ImmunOthersapy Market Size (M USD), 2024-2033
Figure 5. Global Adoptive Cellular ImmunOthersapy Market Size (M USD) (2020-2033)
Figure 6. Global Adoptive Cellular ImmunOthersapy Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Adoptive Cellular ImmunOthersapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Adoptive Cellular ImmunOthersapy Product Life Cycle
Figure 13. Adoptive Cellular ImmunOthersapy Sales Share by Manufacturers in 2024
Figure 14. Global Adoptive Cellular ImmunOthersapy Revenue Share by Manufacturers in 2024
Figure 15. Adoptive Cellular ImmunOthersapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Adoptive Cellular ImmunOthersapy Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Adoptive Cellular ImmunOthersapy Revenue in 2024
Figure 18. Industry Chain Map of Adoptive Cellular ImmunOthersapy
Figure 19. Global Adoptive Cellular ImmunOthersapy Market PEST Analysis
Figure 20. Global Adoptive Cellular ImmunOthersapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Adoptive Cellular ImmunOthersapy Market Share by Type
Figure 27. Sales Market Share of Adoptive Cellular ImmunOthersapy by Type (2020-2025)
Figure 28. Sales Market Share of Adoptive Cellular ImmunOthersapy by Type in 2024
Figure 29. Market Size Share of Adoptive Cellular ImmunOthersapy by Type (2020-2025)
Figure 30. Market Size Share of Adoptive Cellular ImmunOthersapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Adoptive Cellular ImmunOthersapy Market Share by Application
Figure 33. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Application (2020-2025)
Figure 34. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Application in 2024
Figure 35. Global Adoptive Cellular ImmunOthersapy Market Share by Application (2020-2025)
Figure 36. Global Adoptive Cellular ImmunOthersapy Market Share by Application in 2024
Figure 37. Global Adoptive Cellular ImmunOthersapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Adoptive Cellular ImmunOthersapy Sales Market Share by Region (2020-2025)
Figure 39. Global Adoptive Cellular ImmunOthersapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Adoptive Cellular ImmunOthersapy Sales Market Share by Country in 2024
Figure 43. North America Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Adoptive Cellular ImmunOthersapy Market Size Market Share by Country in 2024
Figure 45. U.S. Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Adoptive Cellular ImmunOthersapy Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Adoptive Cellular ImmunOthersapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Adoptive Cellular ImmunOthersapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Adoptive Cellular ImmunOthersapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Adoptive Cellular ImmunOthersapy Sales Market Share by Country in 2024
Figure 53. Europe Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Adoptive Cellular ImmunOthersapy Market Size Market Share by Country in 2024
Figure 55. Germany Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Adoptive Cellular ImmunOthersapy Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Adoptive Cellular ImmunOthersapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Adoptive Cellular ImmunOthersapy Market Size Market Share by Region in 2024
Figure 68. China Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Adoptive Cellular ImmunOthersapy Sales and Growth Rate (K MT)
Figure 79. South America Adoptive Cellular ImmunOthersapy Sales Market Share by Country in 2024
Figure 80. South America Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (M USD)
Figure 81. South America Adoptive Cellular ImmunOthersapy Market Size Market Share by Country in 2024
Figure 82. Brazil Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Adoptive Cellular ImmunOthersapy Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Adoptive Cellular ImmunOthersapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Adoptive Cellular ImmunOthersapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Adoptive Cellular ImmunOthersapy Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Adoptive Cellular ImmunOthersapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Adoptive Cellular ImmunOthersapy Production Market Share by Region (2020-2025)
Figure 103. North America Adoptive Cellular ImmunOthersapy Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Adoptive Cellular ImmunOthersapy Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Adoptive Cellular ImmunOthersapy Production (K MT) Growth Rate (2020-2025)
Figure 106. China Adoptive Cellular ImmunOthersapy Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Adoptive Cellular ImmunOthersapy Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Adoptive Cellular ImmunOthersapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Adoptive Cellular ImmunOthersapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Adoptive Cellular ImmunOthersapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Adoptive Cellular ImmunOthersapy Sales Forecast by Application (2026-2033)
Figure 112. Global Adoptive Cellular ImmunOthersapy Market Share Forecast by Application (2026-2033)
